17-phenyl-18,19,20-trinor-PGF2alpha-1-isopropyl ester,
17-phenyl-18,19,20-trinor-prostaglandin F2 alpha-1-isopropyl ester,
PhDH100A,
17-Phenyl trinor Pgf2alpha-Ipr,
UNII-1IFH52MD8T,
1IFH52MD8T,
130209-76-6,
17-phenyl-trinor-PGF2alpha isopropyl ester,
Phdh100A,
isopropyl 9S,11R,15S-trihydroxy-17-phenyl-18,19,20-trinor-5Z,13E-prostadienoate,
C26H38O5,
(Z)-Isopropyl 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-enyl)cyclopentyl)hept-5-enoate,
PGF2Alpha,17-phenyl,
AC1NR1JH,
Bimatoprost isopropyl ester,
SCHEMBL1954979,
CHEMBL2111623,
BDBM85339,
17-Phenyl-18,19,20-trinor-pgf2alpha-1-isopropyl ester,
CHEBI:137717,
JGZRPRSJSQLFBO-FWPUOYPASA-N,
HMS3648J18,
BCP29022,
ZINC3793068,
17-Phenyl-18,19,20-trinor-prostaglandin F2alpha-1-isopropyl ester,
LMFA03010124,
RP04510,
(1R-(1alpha(Z),2beta(1E,3S*),3alpha,5alpha))-1-Methylethyl 7-(3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-5-heptenoate,
CAS_130209-76-6,
Y7554,
17-phenyl trinor PGF2(c) paragraph sign-iPr,
SR-01000946519,
SR-01000946519-1,
17-phenyl-trinor-Prostaglandin F2alpha isopropyl ester,
5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-, 1-methylethyl ester, (1R-(1alpha(Z),2beta(1E,3S*),3alpha,5alpha))-,
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-, 1-methylethyl ester, (5Z)-,
Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3S,E)-3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl)-hept-5-enoate,
propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoate,
13-trans-Latanoprost,
C26-H38-O5,
CID5283107,
CS-O-16353,
145773-22-4,